Research Article
The Role of Circulating CD16+CD56+ Natural Killer Cells in the Screening, Diagnosis, and Staging of Colorectal Cancer before Initial Treatment
Table 2
The cutoff value of CD16+CD56+ NK cells in prediction of different CRC stages.
| Groups | AUC | Threshold (% in lymphocytes) | Case numbers | OR (95% CI) | value | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
| Healthy vs. cancer | 0.725 | 19.7 | 48/60: 61/264 | 0.08 (0.04, 0.15) | <0.001 | 80.0 | 76.9 | 44.0 | 94.4 | Healthy+stages 1&2 vs. stages 3&4 | 0.892 | 15.6 | 157/186: 38/138 | 0.07 (0.04, 0.12) | <0.001 | 84.4 | 72.5 | 80.5 | 77.5 | Stages 1&2 vs. stages 3&4 | 0.878 | 15.6 | 109/126: 38/138 | 0.06 (0.03, 0.11) | <0.001 | 86.5 | 72.5 | 74.2 | 85.5 |
|
|
AUC: area under the curve. Case number above the threshold/total case number in corresponding groups. |